Suppr超能文献

简短报告:放射治疗的T1-2 N0期喉鳞状细胞癌中细胞DNA含量的预后重要性

Brief report: prognostic importance of cellular DNA content in T1-2 N0 laryngeal squamous cell carcinomas treated with radiotherapy.

作者信息

Toffoli G, Franchin G, Barzan L, Cernigoi C, Carbone A, Sulfaro S, Franceschi S, Boiocchi M

机构信息

Division of Experimental Oncology 1, Centro di Riferimento Oncologico, Aviano, Italy.

出版信息

Laryngoscope. 1995 Jun;105(6):649-52. doi: 10.1288/00005537-199506000-00017.

Abstract

One hundred fifty-two unselected, consecutive patients with T1-2N0 laryngeal squamous cell carcinoma received radical radiation therapy at the Division of Radiotherapy, Centro di Riferimento Oncologico, Aviano, Italy. Thirty-one (20.4%) of the patients showed disease recurrence or persistence (R/P) after radiotherapy. Flow-cytometric DNA ploidy measurements were performed in 72 cases; 20 had tumor R/P and 52 did not. Tumor R/P occurred more frequently (in 17 [85%] of 20 cases) in patients with diploid tumors. The hazard ratio of recurrence in diploid tumors as compared with aneuploid tumors, after inclusion of all the other significant prognostic factors in a Cox proportional hazards model, was 8.9 (P < .01). Therefore DNA ploidy seems to be an important marker of tumor R/P in patients with T1-2N0 laryngeal carcinoma after radiotherapy.

摘要

152例未经挑选的连续性T1-2N0期喉鳞状细胞癌患者在意大利阿维亚诺肿瘤参考中心放疗科接受了根治性放射治疗。31例(20.4%)患者在放疗后出现疾病复发或持续存在(R/P)。对72例患者进行了流式细胞术DNA倍体检测;其中20例有肿瘤R/P,52例没有。二倍体肿瘤患者中肿瘤R/P更为常见(20例中有17例[85%])。在Cox比例风险模型纳入所有其他显著预后因素后,二倍体肿瘤与非整倍体肿瘤相比的复发风险比为8.9(P < 0.01)。因此,DNA倍体似乎是T1-2N0期喉癌患者放疗后肿瘤R/P的一个重要标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验